lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
197 rows where filing_period = "second_quarter", filing_year = 2011 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1107122 | RED+BLUE STRATEGIES 083b5278-7828-4d75-b631-081680ebf050 | Q2 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2011 | second_quarter | PHA | HR 1946, Community Pharmacy Fairness Act Rules, regualtions and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-07-01T15:05:13.563000-04:00 | |
| 1107482 | MEREDITH MCGEHEE 8ac91a17-fed4-48e4-9a9b-580e8e0b1819 | Q2 | MEREDITH MCGEHEE | 79858 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2011 | second_quarter | PHA | Funding for programs to develop AIDS vaccines tarted toward the developing world; Working with the Global Health Technologies Coalition to educate about research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR and appropriations for USAID R&D and funding for IAVI; Provide information on IAVI's model; Providing input of foreign assistance reform from a global health perspective; Funding and budget issues as related to USAID. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-05T14:28:52.070000-04:00 | |
| 1107576 | CYBER SECURITY RESEARCH CONSULTANTS, LLC dc9fc652-ee94-4ad9-958f-d45c1ce4e110 | Q2 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2011 | second_quarter | PHA | Food and Drug Safety Globalizatin Act Monitoring Dorgan-Snowe Drug Reimportation from Canada Monitoring Protect IP Act | HOUSE OF REPRESENTATIVES,SENATE | 24000 | 0 | 0 | 2011-07-05T21:08:55.563000-04:00 | |
| 1107701 | PARRY, ROMANI, DECONCINI & SYMMS e4c7f653-3e3d-4ced-ae51-7b91d14275cb | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | POZEN, INC. | 2011 | second_quarter | PHA | To provide incentives for new drug development. No specific bills pending. | HOUSE OF REPRESENTATIVES,SENATE | 12000 | 0 | 0 | 2011-07-06T12:49:09.633000-04:00 | |
| 1108066 | PUBLIC AFFAIRS RESOURCES, INC. 9a90fce1-7093-47a9-a6d0-ed902f74b3c4 | Q2 | PUBLIC AFFAIRS RESOURCES, INC. | 31270 | PACKAGING CORPORATION OF AMERICA (PCA) (BOISE INC IS NOW A SUBSIDIARY OF PCA ) | 2011 | second_quarter | PHA | Electronic Professional Inserts in lies of Paper, FDA | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-07T12:58:21.857000-04:00 | |
| 1108335 | RED+BLUE STRATEGIES 6da3b9f9-87ca-4cf0-8d75-a186b8dd77ab | Q2 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2011 | second_quarter | PHA | H.R. 1946 - The Community Pharmacy Fairness Act, which allows for an anti-trust exception for certain pharmacies. Issues regarding the approval and coverage of a recently approved drug, Makena. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-07-08T09:20:06.560000-04:00 | |
| 1108565 | BUCHANAN INGERSOLL & ROONEY PC 2a42bac7-5cbb-410d-b7cc-8290d7153cf3 | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | SHIRE PHARMACEUTICALS INC | 2011 | second_quarter | PHA | Life Sciences Investment Act; ESRD bundling, ESRD Quality Incentive program; orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-07-08T13:19:56.510000-04:00 | |
| 1108695 | INJURED WORKERS PHARMACY 3a6fceb3-eda7-495c-9931-df31d99df3ef | Q2 | INJURED WORKERS PHARMACY | 400765309 | INJURED WORKERS PHARMACY | 2011 | second_quarter | PHA | Transparency of Pharmacy Benefit Managers (Bill sponsored by Rep. Cathy McMorris Rodgers (R-WA) and Sen. Mark Pryor (D-AR) Longshore and Harbor Workers Amendment Act of 2011 sponsored by Sen. Johnny Isakson (R-GA) | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-08T14:40:05.627000-04:00 | ||
| 1108723 | PARRY, ROMANI, DECONCINI & SYMMS 423624a8-f9f1-4bfe-90f4-2b03140f9aae | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2011 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practioner acting in the usual course of professional practice. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T14:58:18.923000-04:00 | |
| 1108726 | PARRY, ROMANI, DECONCINI & SYMMS ac918148-70ff-4dce-b41f-a654227b3c41 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2011 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2011-07-08T15:08:20.700000-04:00 | |
| 1108745 | PARRY, ROMANI, DECONCINI & SYMMS 325761ad-b210-4806-867e-96a937079b48 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2011 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T15:35:33.777000-04:00 | |
| 1108770 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 726911d7-fcb4-49ea-9ce3-f8f8b588f2c7 | Q2 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 1672 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 2011 | second_quarter | PHA | the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 105753 | 0 | 0 | 2011-07-08T15:57:47.607000-04:00 | |
| 1108786 | PARRY, ROMANI, DECONCINI & SYMMS ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2011 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T16:03:55.353000-04:00 | |
| 1108798 | PARRY, ROMANI, DECONCINI & SYMMS 1b4a13f8-f463-4395-b024-66054c7fc74a | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2011 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-07-08T16:16:02.027000-04:00 | |
| 1108812 | INDEPENDENT PHARMACY COOPERATIVE 850445e4-4c28-44eb-996f-65a628ec2ccf | Q2 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2011 | second_quarter | PHA | Short-Cycle dispensing of medication in long-term care facilities. CMS Rule. All provisions DEA Physician/Nurse Agent Definition. H.R. 891 The Medication Therapy Management Benefits Act of 2011. All provisions. S. 274 The Medication Management Empowerment Act of 2011. All provisions H.R. 1971/S. 1058, The Pharmacy Competition and Consumer Choice Act- All provisions H.R. 1946, The Preserving our Hometown Pharmacies Act-All provisions H.R. 971, The Commnit Pharmcy Fairness Act-All provisions H.R. 1936, The Medicare Access to Diabetes Supplies Act-All provisions | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2011-07-08T16:21:05.697000-04:00 | |
| 1108850 | UNIVERSITY OF IOWA e64a6183-f2c1-4dc3-82c4-70f8c3e531c5 | Q2 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2011 | second_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 88684 | 0 | 0 | 2011-07-08T16:38:20.290000-04:00 | |
| 1109088 | DUTKO WORLDWIDE, LLC 88802d2e-e0b6-4598-9327-2eeae5c3f570 | Q2 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2011 | second_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-11T11:26:13.657000-04:00 | |
| 1109168 | HOLLAND & KNIGHT LLP 317a6159-365e-446d-82e7-6d42ed02022e | 2T | HOLLAND & KNIGHT LLP | 18466 | AMERICAN SOCIETY OF HEMATOLOGY | 2011 | second_quarter | PHA | Hematology and Oncology drug research and approval issues. S. 296 Preserving Access to Life-Saving Medications Act. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 1 | 2011-07-11T12:02:58.890000-04:00 | |
| 1109192 | HOLLAND & KNIGHT LLP 6a9d74ff-c691-4d13-9e68-af110e2ca8cb | 2T | HOLLAND & KNIGHT LLP | 18466 | NATIONAL HEMOPHILIA FOUNDATION | 2011 | second_quarter | PHA | Blood and blood product safety; issues related to blood product approvals; Blood donor deferral policies, 340B Drug purchasing program and orphan drugs. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 40000 | 0 | 1 | 2011-07-11T12:08:08.093000-04:00 | |
| 1109464 | AMERICAN COLLEGE OF CLINICAL PHARMACY c604db59-9568-432b-91bb-b3e54d544075 | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2011 | second_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 59600 | 0 | 0 | 2011-07-11T14:57:37.943000-04:00 | |
| 1110334 | AMERICAN VETERINARY MEDICAL ASSOCIATION a760cad4-38fb-4b7f-8812-86513e0548fa | Q2 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 3630 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 2011 | second_quarter | PHA | H.R. 962/S. 1211 Preservation of Antibiotics for Medical Treatment Act H.R. 1406 Fairness to Pet Owners Act | Agriculture, Dept of (USDA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 170000 | 0 | 0 | 2011-07-12T15:29:02.597000-04:00 | |
| 1111007 | VENABLE LLP 61d9f255-50c0-416e-a264-7dc5d6e805a9 | Q2 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2011 | second_quarter | PHA | General issues affecting the pharmaceutical industry The Life Sciences Investment Act | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-07-13T11:09:32.397000-04:00 | |
| 1112073 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 300de1dc-ecb0-468e-a302-8f89be1c780f | Q2 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 309377 | ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 2011 | second_quarter | PHA | Support legislation that would allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-14T10:40:04.627000-04:00 | ||
| 1113250 | MCKENNA, LONG & ALDRIDGE 3d5ebf68-0236-4bf7-9a95-904ab5b55689 | Q2 | MCKENNA, LONG & ALDRIDGE | 76913 | REVANCE THERAPEUTICS, INC. | 2011 | second_quarter | PHA | Any issues impacting biopharmaceutical companies | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-14T22:14:35.867000-04:00 | |
| 1113432 | PD FRAZER CONSULTING, INC. 45267b38-de9b-4d1c-a0b3-d3b42e3009ac | Q2 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2011 | second_quarter | PHA | Monitor the development of proposed bills about the importation of prescribed drugs. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-07-15T09:38:59.827000-04:00 | |
| 1113442 | PD FRAZER CONSULTING, INC. be0fa0c4-b837-43c8-89a4-4f42161e8aec | Q2 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2011 | second_quarter | PHA | Monitor the development of proposed bills about the importation of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-07-15T09:48:07.313000-04:00 | |
| 1113541 | THE OB-C GROUP, LLC d7ac7f70-1900-4dfe-b34d-f50f25a687f9 | Q2 | THE OB-C GROUP, LLC | 29802 | ELI LILLY | 2011 | second_quarter | PHA | No specific bill number: matters relating to pharmaceutical manufacturers. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-15T10:42:01.487000-04:00 | |
| 1113767 | RASKY PARTNERS, INC. 91ac2923-2548-4017-b30e-790d18527738 | Q2 | RASKY PARTNERS, INC. | 297410 | ELI LILLY AND CO | 2011 | second_quarter | PHA | Monitor biologics related issues | HOUSE OF REPRESENTATIVES,SENATE | 22500 | 0 | 0 | 2011-07-15T11:41:02.987000-04:00 | |
| 1114072 | FAEGRE BAKER DANIELS CONSULTING 8625094f-8486-4584-b854-192170444ca6 | Q2 | FAEGRE BAKER DANIELS CONSULTING | 34158 | ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) | 2011 | second_quarter | PHA | ONLINE PHARMACIES | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-15T12:49:47.940000-04:00 | |
| 1114518 | GENENTECH, INC c0acace8-c62f-489c-b8d4-47049f65432c | Q2 | GENENTECH, INC | 15920 | GENENTECH INC | 2011 | second_quarter | PHA | Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicar prescription drug benefit. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription. drug benefit. General issue and congressional oversight related to FDA approval and CMS coverage decisions regarding. Avastin and Lucentis. | HOUSE OF REPRESENTATIVES,SENATE | 1140295 | 0 | 0 | 2011-07-15T15:29:33.307000-04:00 | |
| 1114565 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) a565f6e7-997e-4827-9753-c222d5dec955 | Q2 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2011 | second_quarter | PHA | Importation of prescription drugs (S. 319, H.R. 147); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation; NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245); Cargo/Product Theft (S. 1002); Issues related to DEA drug diversion programs | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 272000 | 0 | 0 | 2011-07-15T15:39:54.980000-04:00 | |
| 1114678 | NOVO NORDISK INC. 4f90aa5a-f3d0-460a-88d1-e6b185ee2f97 | Q2 | NOVO NORDISK INC. | 284790 | NOVO NORDISK INC. | 2011 | second_quarter | PHA | P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE | 550000 | 0 | 0 | 2011-07-15T16:34:57.150000-04:00 | |
| 1114796 | NAHIGIAN STRATEGIES, LLC 112002fe-a502-41d8-9d81-1386b0832321 | Q2 | NAHIGIAN STRATEGIES, LLC | 322897 | TEVA PHARMACEUTICALS USA INC | 2011 | second_quarter | PHA | Generic Pharmaceutical Issues | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-15T17:09:45.290000-04:00 | |
| 1114835 | RED+BLUE STRATEGIES 993fe83e-a2d6-48ea-b949-2eaaf357a39f | Q2 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2011 | second_quarter | PHA | H.R. 2182, the Generating Antibiotic Incentives Now Act, in support of innovations in the development of new antibiotics Issues related to upstream and downstream supply chain safety | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-15T17:18:16.807000-04:00 | |
| 1115037 | THORN RUN PARTNERS 372041e0-1a58-4520-bbdd-4183ce001f77 | Q2 | THORN RUN PARTNERS | 400534596 | LONG TERM CARE PHARMACY ALLIANCE | 2011 | second_quarter | PHA | Issues related to the implementation of the Affordable Care Act (ACA) and DEA enforcement of controlled substances in nursing homes. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-16T14:05:25.363000-04:00 | |
| 1115442 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC b604e3fa-bbbb-4f0d-a64a-ecb5c025efbf | Q2 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC | 400689052 | WOCKHARDT USA LLC | 2011 | second_quarter | PHA | Preemption under the FDA Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-17T16:53:27.630000-04:00 | |
| 1115913 | SQUIRE PATTON BOGGS 99bd03d6-bd66-47ac-8bc8-1116ca275083 | Q2 | SQUIRE PATTON BOGGS | 30906 | RANBAXY INC. | 2011 | second_quarter | PHA | S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; S. 23/H.R. 1249 the America Invents Act; H.R. 1, Full Year Continuing Appropriations Act; H.R. 2112, Agriculture, Rural Development, Food & Drug Administration, and Related Agencies Appropriations Act of 2012. | HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2011-07-18T07:51:59.517000-04:00 | |
| 1116097 | ALCALDE & FAY 68895267-0d78-421b-bb90-8b93171599fd | Q2 | ALCALDE & FAY | 818 | CITY OF KENMORE, WASHINGTON | 2011 | second_quarter | PHA | Expired drug reclamation programs | Army, Dept of (Corps of Engineers),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T09:21:22.010000-04:00 | |
| 1116136 | EISAI INC. 6e98dad6-4517-4475-a6c8-cb5b184336b6 | Q2 | EISAI INC. | 400321512 | EISAI INC. | 2011 | second_quarter | PHA | Drug issues, generally. Prescription Drug User Fee Act reauthorization. FDA-DEA issues biosimilars implementation | HOUSE OF REPRESENTATIVES,SENATE | 670000 | 0 | 0 | 2011-07-18T09:31:38.217000-04:00 | |
| 1116144 | ACADEMY OF MANAGED CARE PHARMACY 954799f7-6324-49a9-b2f8-e93bbbe8f03b | Q2 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2011 | second_quarter | PHA | S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufacturer agrees to delay entry into the market in exchange for compensation from the manufacturer of the innovator product. HR 1483 - legislation that would introduce reforms and reauthorizations of the FDA, including the prescription drug user fee act | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2011-07-18T09:32:41.903000-04:00 | |
| 1116334 | POLICY DIRECTIONS INC. e539144a-08d4-4d83-80bb-7261192c15f6 | Q2 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2011 | second_quarter | PHA | Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-18T10:13:15.633000-04:00 | |
| 1116491 | WHITMER & WORRALL, LLC 195e8f5f-0d16-4e57-a9bf-89295f25134f | Q2 | WHITMER & WORRALL, LLC | 292892 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2011 | second_quarter | PHA | Issues related to monitoring healthcare reform. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-18T10:31:27.120000-04:00 | |
| 1116881 | BROWN RUDNICK LLP 918dea0c-bfcd-4440-9aed-87dd6af1a03a | Q2 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2011 | second_quarter | PHA | Issues related to supply chain safety and DEA drug; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-18T11:22:23.837000-04:00 | |
| 1116967 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS a959d414-3c7b-4a13-b8fc-9c36edd1f6b0 | Q2 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2011 | second_quarter | PHA | Communication with Government Accountability Office concerning its study (required under section 7103, P.L. 111-148) on improving the 340B drug discount program. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 250000 | 0 | 0 | 2011-07-18T11:34:05.757000-04:00 | |
| 1117154 | HEARTLAND SOLUTIONS GROUP, INC. a905ff39-5435-48e8-8d50-193d6effd776 | Q2 | HEARTLAND SOLUTIONS GROUP, INC. | 312133 | ZEBRA TECHNOLOGIES CORPORATION | 2011 | second_quarter | PHA | Any and all issues related to barcode, secure identification and real-time location systems. | Army, Dept of (Other),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-07-18T12:18:45.430000-04:00 | |
| 1117489 | THE RUSSELL GROUP, INC. b6116080-2973-41fa-a978-7cfc68b42947 | Q2 | THE RUSSELL GROUP, INC. | 22688 | GENERIC PHARMACEUTICAL ASSOCIATION | 2011 | second_quarter | PHA | Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011). | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 50000 | 0 | 0 | 2011-07-18T13:29:37.773000-04:00 | |
| 1117959 | EMPIRE CONSULTING GROUP f85956c1-ff3d-4a57-80ed-f5dbff28013a | Q2 | EMPIRE CONSULTING GROUP | 400703105 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2011 | second_quarter | PHA | H.R. 1249 "America Invents Act" (Patent Reform); H.R. 452, Independent Payment Advisory Board ("IPAB") Repeal; Medicare Part D Rebates (during deficit reduction discussions); and Prescription Drug Diversion | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2011-07-18T14:32:21.647000-04:00 | |
| 1118204 | SMITH GARSON FKA SMITH DAWSON & ANDREWS c0220ad9-2cc4-4e96-9011-0107be06d716 | 2T | SMITH GARSON FKA SMITH DAWSON & ANDREWS | 35707 | STRUVE SWINE TECHNOLOGIES | 2011 | second_quarter | PHA | Government Advertisement of Biopharmaceuticals | 0 | 1 | 2011-07-18T14:59:28.083000-04:00 | |||
| 1118211 | SMITH GARSON FKA SMITH DAWSON & ANDREWS 22b08f3a-42d9-40fe-9af0-5422feb1ca90 | 2T | SMITH GARSON FKA SMITH DAWSON & ANDREWS | 35707 | PROSETTA CORPORATION | 2011 | second_quarter | PHA | Government Advertisement of Biopharmaceuticals | 0 | 1 | 2011-07-18T14:59:32.067000-04:00 | |||
| 1118309 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 7414be3a-106a-429f-a7fd-9ab751d08626 | Q2 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 31348 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 2011 | second_quarter | PHA | H.R. 1409: All provisions of the Quality Health Care Coalition Act of 2011; H.R. 891/S. 274: All provisions of the Medication Therapy Management Benefits Act of 2011; H.R. 905 /S. 733:All provisions of the legislation to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare; H.R. 979All provisions of the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 605 / S. 312All provisions of the Patients Freedom to Choose Act S. 27 All provisions of the Preserve Access to Affordable Generics Act S. 31All provisions of the Prescription Drug and Health Improvement Act of 2011 S. 44All provisions of the Medicare Prescription Drug Price Negotiation Act of 2011 H.R. 999 / S. 560All provisions of the Medicare Prescription Drug Savings and Choice Act of 2011 H.R. 1839 All provisions of the Community Pharmacy Fairness Act of 2011; H.R. 1946 All provisions of the Preserving or Hometown Independent Pharmacies Act of 2011; H.R. 1971 / S. 1058 All provisions of the Pharmacy Competition and Consumer Choice Act of 2011 Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio) Regulatory and proposed legislative changes to Medicare part D including EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs FDA issues related to the Prescription Drug User Fee Act (PD… | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE | 524738 | 0 | 0 | 2011-07-18T15:14:20.377000-04:00 | |
| 1119634 | SQUIRE PATTON BOGGS c85dccf9-e6b4-4650-9ad0-922333419c76 | Q2 | SQUIRE PATTON BOGGS | 30906 | KV PHARMACEUTICAL COMPANY | 2011 | second_quarter | PHA | Prescription drug coverage and pricing for progesterone injection. | HOUSE OF REPRESENTATIVES,SENATE | 310000 | 0 | 0 | 2011-07-19T08:01:11.407000-04:00 | |
| 1119647 | SQUIRE PATTON BOGGS c9360c63-62f9-4dbc-9585-9acef8600a1c | Q2 | SQUIRE PATTON BOGGS | 30906 | SUNOVION PHARMACEUTICALS INC | 2011 | second_quarter | PHA | Issues related to respiratory drug coverage and H.R. 3590. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-19T08:07:19.937000-04:00 | |
| 1119863 | UPS (UNITED PARCEL SERVICE) 6fb6a0e0-391f-4c48-83f7-016e985f1c57 | Q2 | UPS (UNITED PARCEL SERVICE) | 39223 | UPS (UNITED PARCEL SERVICE) | 2011 | second_quarter | PHA | - FDA Track and Trace - HHS/CDC PEPFAR Grant for Supply - Pedigree - Serialization | Commerce, Dept of (DOC),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office | 1069998 | 0 | 0 | 2011-07-19T09:38:08.140000-04:00 | |
| 1120133 | CAPITOL HILL CONSULTING GROUP acdba1f8-d4e5-43c1-accd-bd805a709fe5 | Q2 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2011 | second_quarter | PHA | Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-19T10:16:10.187000-04:00 | |
| 1120473 | MCDERMOTT WILL & SCHULTE LLP 63e89ea4-62c0-403a-aff8-6d0f9e178911 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ISIS PHARMACEUTICALS | 2011 | second_quarter | PHA | Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-07-19T10:50:42.557000-04:00 | |
| 1121834 | VAN SCOYOC ASSOCIATES 7e80aa95-297d-4755-b8fb-17074a394e9a | Q2 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF CONNECTICUT | 2011 | second_quarter | PHA | FDA salaries and expenses; and extramural research related issues: H.R.2112,Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-19T12:59:04.103000-04:00 | |
| 1121850 | VAN SCOYOC ASSOCIATES 46b3f3e7-ba4d-4d86-981d-8b41e8a3299a | Q2 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF MARYLAND BALTIMORE | 2011 | second_quarter | PHA | No lobbying activity. | Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2011-07-19T13:01:11.743000-04:00 | |
| 1121871 | VAN SCOYOC ASSOCIATES 4cf1fb09-3114-4918-a493-3a59f0074644 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE | 2011 | second_quarter | PHA | FDA and USDA funding initiatives; Critical Path Partnership. H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-19T13:01:18.790000-04:00 | |
| 1122017 | EXPRESS SCRIPTS, INC. 7b454d19-0fe2-440f-8b8f-e8246a13c441 | Q2 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2011 | second_quarter | PHA | Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (essential health benefits, grandfathering, value-base insurance design, Rx quality, electronic prescribing, PBM disclosure requirements, medical loss ratio); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; Implementation of Zadroga Health Care Act; Legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058) | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,White House Office | 450000 | 0 | 0 | 2011-07-19T13:22:18.117000-04:00 | |
| 1122135 | MCDERMOTT WILL & SCHULTE LLP cab922a1-4dad-4805-8259-15456a2823ab | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2011 | second_quarter | PHA | Issues related to Section 340B of the Public Health Service Act. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-07-19T13:34:15.523000-04:00 | |
| 1122206 | ELI LILLY AND COMPANY 9916fbe2-eee2-4bb7-9639-503cfafb46b1 | Q2 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2011 | second_quarter | PHA | Hospital discounts (HR 3590) | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office | 1945000 | 0 | 0 | 2011-07-19T13:41:45.523000-04:00 | |
| 1122402 | MCDERMOTT WILL & SCHULTE LLP 2ffab682-02c4-40c2-bae1-421e6cb6fb0b | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2011 | second_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-19T14:04:20.117000-04:00 | |
| 1122452 | AKIN GUMP STRAUSS HAUER & FELD a9d12bfc-1453-4cf6-bb69-840611967de1 | Q2 | AKIN GUMP STRAUSS HAUER & FELD | 682 | PRASCO, INC. | 2011 | second_quarter | PHA | Promoting consumer benefits of authorized generic drugs | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-19T14:08:44.053000-04:00 | ||
| 1122552 | BUCHANAN INGERSOLL & ROONEY PC 3ea5b65f-f3d8-4de3-91ab-dd6dbb74b9b1 | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GENERIC ANIMAL DRUG ALLIANCE | 2011 | second_quarter | PHA | Legislative issues relating to United States Food & Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-19T14:16:23.747000-04:00 | |
| 1122585 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION b7d97fe0-2bf6-4e10-afd8-d523a7285fbc | Q2 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2011 | second_quarter | PHA | Over-the-Counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA H.R. 1483 - Drug Safety Enhancement Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand drug establishment registration requirements to include foreign drug establishments and other purposes; all sections. | HOUSE OF REPRESENTATIVES,SENATE | 250000 | 0 | 0 | 2011-07-19T14:19:36.733000-04:00 | |
| 1122753 | APOTEX CORP. f954f602-f0db-4c71-82e1-e677617cbfc2 | Q2 | APOTEX CORP. | 310973 | APOTEX CORP. | 2011 | second_quarter | PHA | S. 27, the Preserve Access to Affordable Pharmaceuticals Act Amending Section 505(j) of the Food, Drug, and Comsetic Act, concerning the ability of generic pharmaceutical manufacturers to file counterclaims seeking the correction of incorrect information submitted to FDA's Orange Book by patent owners or holders of New Drug Applications Supreme Court consideration of Novo Nordisk A/S and Novo Nordisk Inc. vs Carco Pharmaceutical Laboratories Ltd and Sun Pharmaceuticals Industries, Ltd Prospective action on legislation establishing a generic drug user fee program Prospection action on legislation establishing a biosimilar user fee program S. 296, the Preserving Access to Life Saving Medications Act Establishment of a federal track and trace system for pharmaceuticals | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 240000 | 0 | 0 | 2011-07-19T14:32:49.823000-04:00 | |
| 1122768 | GOVBIZ ADVANTAGE, INC. 2444ad2e-52d1-4ba1-a12c-7b329424f9f5 | Q2 | GOVBIZ ADVANTAGE, INC. | 294234 | CATALYST HEALTH SOLUTIONS (CATAMARANRX) | 2011 | second_quarter | PHA | Pharmacy Benefit Issues in health legislation; PBM issues; General company congressional relations; business issues | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-19T14:34:57.010000-04:00 | |
| 1122832 | BUCHANAN INGERSOLL & ROONEY PC 9e2f4cdf-7d05-4f13-bba1-0d55cfd68fa3 | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | IPEC - AMERICAS, INC. | 2011 | second_quarter | PHA | FDA Globalization Acts and legislation related to supply chain security and drug contamination issues | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-19T14:41:28.433000-04:00 | |
| 1122843 | EVERTZ GROUP LLC 4536572c-7dc2-47ca-b7d3-4465c61615a1 | Q2 | EVERTZ GROUP LLC | 400497446 | MYLAN INC. | 2011 | second_quarter | PHA | Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. | Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) | 30000 | 0 | 0 | 2011-07-19T14:41:33.150000-04:00 | |
| 1122969 | BUCHANAN INGERSOLL & ROONEY PC 4906f981-53ec-4e7b-9863-4e8ca04750fb | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO | 2011 | second_quarter | PHA | Patent reform, drug importation; Life Science Investment Act; drug exception from Pharma fee; medical device tax. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-19T14:49:28.383000-04:00 | |
| 1123245 | HANCE SCARBOROUGH a13c7807-4bb6-49a9-aba2-2dd359ee479d | Q2 | HANCE SCARBOROUGH | 17443 | INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) | 2011 | second_quarter | PHA | Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-19T15:06:33.900000-04:00 | |
| 1123845 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES d767c79c-9aec-4682-919e-67e732f36e32 | Q2 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2011 | second_quarter | PHA | S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE | 580000 | 0 | 0 | 2011-07-19T15:48:54.523000-04:00 | |
| 1124017 | HANCE SCARBOROUGH ddbb5860-9b7f-4c75-863a-0dd7aa50540f | Q2 | HANCE SCARBOROUGH | 17443 | TEXAS ACADEMY OF COMPOUNDING PHARMACISTS | 2011 | second_quarter | PHA | Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-19T16:03:24.650000-04:00 | |
| 1124083 | AMYLIN PHARMACEUTICALS 9ad56e7c-4f41-47c2-b396-efbe5f2c3b36 | Q2 | AMYLIN PHARMACEUTICALS | 308536 | AMYLIN PHARMACEUTICALS | 2011 | second_quarter | PHA | Perscription Drug User Fee Act reauthorization FDA funding and agency effectiveness Drug importation issues | HOUSE OF REPRESENTATIVES,SENATE | 230000 | 0 | 0 | 2011-07-19T16:09:54.103000-04:00 | |
| 1124167 | UNIVERSITY OF CONNECTICUT aec658b1-0eae-48cf-bfc0-7c887b3000d9 | Q2 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2011 | second_quarter | PHA | FDA Salaries and expenses; and extramural research related issues: H.R.2112, Agriculture, Rural Developmetn, Food and Drug Administration and Related Ageneies Appropriations Act, FY2012. Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011. Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY-2011; | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-07-19T16:15:31.460000-04:00 | |
| 1124295 | AMERICAN PHARMACISTS ASSOCIATION 4329ab28-0f49-4cbc-b438-db5c005bc15b | Q2 | AMERICAN PHARMACISTS ASSOCIATION | 3071 | AMERICAN PHARMACISTS ASSOCIATION | 2011 | second_quarter | PHA | S.48 Pharmacist Loan Repayment Eligibility Act of 2011 Agency issues relating to risk evaluation and mitigation strategies (REMS); the Prescription Drug User Fee Act (PDUFA); prescription drug monitoring programs; prescription drug abuse; and safety of the drug supply chain. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 167951 | 0 | 0 | 2011-07-19T16:24:41.697000-04:00 | |
| 1124314 | BATES CAPITOL GROUP, INC. 4f2278cf-bfd5-4260-b7ab-02cdfcbc184f | Q2 | BATES CAPITOL GROUP, INC. | 400656969 | C2 GROUP (ON BEHALF OF BIOTECHNOLOGY INDUSTRY ORGANIZATION) | 2011 | second_quarter | PHA | Support strong and fully funded FDA review process. | SENATE | 20000 | 0 | 0 | 2011-07-19T16:27:01.273000-04:00 | |
| 1124518 | VAN HEUVELEN STRATEGIES, LLC a5efa27e-d9ad-4f9f-be5e-eceae2c8d74e | Q2 | VAN HEUVELEN STRATEGIES, LLC | 321874 | DAVITA | 2011 | second_quarter | PHA | Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, CMS reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. | HOUSE OF REPRESENTATIVES,SENATE | 210000 | 0 | 0 | 2011-07-19T16:37:21.523000-04:00 | |
| 1125089 | GEPHARDT GROUP GOVERNMENT AFFAIRS 357a9104-20ff-46f3-a31c-b230c0aff68a | Q2 | GEPHARDT GROUP GOVERNMENT AFFAIRS | 315717 | HEALIANCE PHARMACEUTICALS | 2011 | second_quarter | PHA | innovative diabetes treatment | HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE,State, Dept of (DOS),Treasury, Dept of | 20000 | 0 | 0 | 2011-07-19T17:12:50.803000-04:00 | |
| 1125146 | 340B HEALTH a8aeb5d0-d98f-4597-a24b-84eeddb9dc65 | Q2 | 340B HEALTH | 316434 | 340B HEALTH | 2011 | second_quarter | PHA | Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities. | Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 262810 | 0 | 0 | 2011-07-19T17:17:15.520000-04:00 | |
| 1125171 | TARPLIN, DOWNS & YOUNG, LLC 50c1c388-eed0-4fc1-9063-65257bfe7220 | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2011 | second_quarter | PHA | **see addendum page Importation of prescription drugs (S.319/H.R. 147) Methamphetamine/Pseudoephedrine Regulation NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245) Rx Pedigree Cargo/Product Theft (S. 1002) **no specific bills, federal pedigree, import safety | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-07-19T17:19:25.523000-04:00 | |
| 1125323 | ASSOCIATION FOR ACCESSIBLE MEDICINES 4897cbc8-4d12-4475-b1fd-80ef8aa0d7e6 | Q2 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 16032 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 2011 | second_quarter | PHA | FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug User Fees, Authorized Generics, Prescription Drug Importation/Re-Importation, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office | 508375 | 0 | 0 | 2011-07-19T17:28:24.007000-04:00 | |
| 1125349 | FOLEY & LARDNER LLP 845a75ad-9d6a-413b-8eaa-e9e01c623a32 | Q2 | FOLEY & LARDNER LLP | 15042 | ROMARK LABORATORIES, LC | 2011 | second_quarter | PHA | Sale of new anti-viral drug | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-19T17:29:34.710000-04:00 | ||
| 1125432 | GREATER NEW YORK HOSPITAL ASSOCIATION 8a23e2f8-4484-4705-8b18-1cc4ee9f287b | Q2 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2011 | second_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), medical device pricing issues, and preserving access to group purchasing organizations. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 470000 | 0 | 0 | 2011-07-19T17:34:05.897000-04:00 | |
| 1125793 | GREENBERG TRAURIG, LLP f2fa1c85-0f4f-4fb6-9c26-1c1f3eef44ee | Q2 | GREENBERG TRAURIG, LLP | 16896 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) | 2011 | second_quarter | PHA | Health care legislative and regulatory issues affecting independent community pharmacies. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) | 20000 | 0 | 0 | 2011-07-19T18:09:43.397000-04:00 | |
| 1125838 | GREENBERG TRAURIG, LLP 0edf6295-7951-4e73-8269-62ea4637c207 | Q2 | GREENBERG TRAURIG, LLP | 16896 | RICHIE & GUERINGER, P.C. | 2011 | second_quarter | PHA | Congressional actions on health care reform. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-07-19T18:15:05.943000-04:00 | ||
| 1125939 | BLUESTONE STRATEGIES, LLC f797d403-7730-4a14-ad86-1d9d82042ada | Q2 | BLUESTONE STRATEGIES, LLC | 400658980 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2011 | second_quarter | PHA | Pharmacy Act; Drug Reimportation; Generic Brand Settlement; Generic Dispensing; Generic Biologics; Speciality Drug Issues | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-19T18:25:49.740000-04:00 | |
| 1126023 | MARSHFIELD CLINIC HEALTH SYSTEM 2c6d964d-3357-4b54-9677-b2c937d1392b | Q2 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2011 | second_quarter | PHA | Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2011-07-19T18:46:25.220000-04:00 | |
| 1126374 | SHIRE PHARMACEUTICALS LLC f281434a-1bfe-4213-8ec3-aa932f2838d8 | Q2 | SHIRE PHARMACEUTICALS LLC | 323477 | SHIRE PHARMACEUTICALS LLC | 2011 | second_quarter | PHA | S. 296, Preserving Access to Life Saving Medicines Act; Life Sciences Investment Act; orphan drugs; end stage renal disease (ESRD) bundling of non-injectable oral equivalents; ESRD Quality Incentive program; Prescription Drug User Fee program; reimbursements; drug shortages; DEA quotas | SENATE | 90000 | 0 | 0 | 2011-07-19T20:02:59.487000-04:00 | |
| 1126410 | WINBORN SOLUTIONS LLC c591644f-2426-4db3-a39c-9ec04402655a | Q2 | WINBORN SOLUTIONS LLC | 308310 | PERRIGO CO | 2011 | second_quarter | PHA | Generic drug user fee legislation | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2011-07-19T20:10:17.987000-04:00 | |
| 1126459 | DOW LOHNES GOVERNMENT STRATEGIES LLC c42fffa4-154f-4ae8-a06f-0b3eaaf9c0b7 | Q2 | DOW LOHNES GOVERNMENT STRATEGIES LLC | 316013 | AMERISOURCEBERGEN CORPORATION | 2011 | second_quarter | PHA | H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree history, wholesale transaction documentation, and electronic tracking; Federal policy related to wet AMD pharmaceutical products and pricing. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-07-19T20:25:41.627000-04:00 | |
| 1126655 | AVENUE SOLUTIONS 6d48df77-92e8-42c4-b311-63230781cac6 | Q2 | AVENUE SOLUTIONS | 72111 | EXPRESS SCRIPTS INC | 2011 | second_quarter | PHA | Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service and 5-day mail delivery; HR 979, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 27, Preserve Access to Affordable Generics Act; HR 1041, Fairness in Medicare Bidding; HR 1946, Preserving Our Hometown Independent Pharmacies Act; S 1058, Pharmacy Competition and Consumer Choice Act of 2011 | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2011-07-19T21:37:24.017000-04:00 | |
| 1127477 | WINNING STRATEGIES WASHINGTON a26bb64f-17b3-4c7b-bf64-963da08cf475 | 2T | WINNING STRATEGIES WASHINGTON | 50796 | MEDA PHARMACEUTICALS | 2011 | second_quarter | PHA | FDA Risk Evaluation and Mitigation Strategies | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2011-07-20T09:09:46.460000-04:00 | |
| 1127485 | NOSSAMAN LLP afa54004-8230-459e-b250-36da3f7a613e | Q2 | NOSSAMAN LLP | 29846 | AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") | 2011 | second_quarter | PHA | H.R.905 and S.733, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-07-20T09:11:52.270000-04:00 | |
| 1128024 | OMNICARE, INC. a98868eb-29d9-4a0e-8a5b-d36d1a605044 | Q2 | OMNICARE, INC. | 321112 | OMNICARE INC | 2011 | second_quarter | PHA | Modify Drug Enforcement Administration policy on dispensing of controlled substances to residents of nursing homes. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 98000 | 0 | 0 | 2011-07-20T09:54:51.083000-04:00 | |
| 1128797 | FOOD MARKETPLACE INC. c801d332-6a61-4bc7-b8d9-e079804c666c | Q2 | FOOD MARKETPLACE INC. | 15097 | FOOD MARKETPLACE INC | 2011 | second_quarter | PHA | Proposed Rule: CMS-1345-P; Medicare Shared Savings Program; Accountable Care Organization (76 FR 19528) | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Federal Deposit Insurance Corporation (FDIC),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),SENATE,Treasury, Dept of,White House Office | 610000 | 0 | 0 | 2011-07-20T10:44:29.270000-04:00 | |
| 1129027 | WALGREEN COMPANY 9098fb5d-3d4d-418d-aef0-37ee3f3e15cd | Q2 | WALGREEN COMPANY | 309071 | WALGREEN COMPANY | 2011 | second_quarter | PHA | Drug safety-no specific legislation-regarding any discussions surrounding the security of the drug supply chain. H.R.1540/S. 981- the "National Defense Authorization Act of FY 2012"- provisions related to the TRICARE program. | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 630000 | 0 | 0 | 2011-07-20T10:57:14.267000-04:00 | |
| 1129148 | CVS HEALTH (AND SUBSIDIARIES) 739decf2-a4f6-45a1-926c-66c11b9866df | Q2 | CVS HEALTH (AND SUBSIDIARIES) | 302778 | CVS CAREMARK INC | 2011 | second_quarter | PHA | Issues related to drug safety and the drug supply chain. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 2287321 | 0 | 0 | 2011-07-20T11:05:06.580000-04:00 | |
| 1129610 | JONES PUBLIC AFFAIRS, INC. c9b527cf-4aa7-4079-bc96-ac6ca651dae1 | Q2 | JONES PUBLIC AFFAIRS, INC. | 400738211 | THE SAFDAR GROUP (ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES) | 2011 | second_quarter | PHA | Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-07-20T11:27:18.017000-04:00 | |
| 1129756 | THE UNITED STATES PHARMACOPEIAL CONVENTION a67d678f-3c83-45ec-80cd-55931984befa | Q2 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 400358632 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 2011 | second_quarter | PHA | - Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients. - H.R. 1483, "Drug Safety Enhancement Act of 2011", regarding Section 102 on drug supply quality and safety. - H.R. 2227, "Medical Gas Safety Act", regarding Section 3, Regulation of Medical Gases. - H. 2112, "Agriculture Appropriations Bill, FY 2012", regarding support for FDA funding. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE | 60000 | 0 | 0 | 2011-07-20T11:34:24.487000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);